Altered peptide ligands: Prospects for immune intervention in autoimmune disease

Altered peptide ligands: Prospects for immune intervention in autoimmune disease

Show other versions (1)

Bibliographic Details
Main Author:	Fairchild, P
Format:	Journal article
Published:	1997

Similar Items

Altered peptide ligands: prospects for immune intervention in autoimmune disease.
by: Fairchild, P
Published: (1997)

Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby
by: Chen, T, et al.
Published: (2004)

Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby.
by: Chen, T, et al.
Published: (2004)

Immune evasion in malaria: altered peptide ligands of the circumsporozoite protein.
by: Plebanski, M, et al.
Published: (1997)

Natural altered peptide ligands in HIV infection
by: Klenerman, P, et al.
Published: (1996)

Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases
by: Luz P. Blanco, et al.
Published: (2023-04-01)

Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases.
by: Luz P Blanco, et al.
Published: (2023-04-01)

Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming.
by: Plebanski, M, et al.
Published: (1999)

Epigenetic Alterations in Cellular Immunity: New Insights into Autoimmune Diseases
by: Zijun Wang, et al.
Published: (2017-02-01)

Prospect of Gut Microbiota-based Intervention in Autoimmune Disease Control
by: ZHAO Lidan, et al.
Published: (2022-09-01)

Nectin Family Ligands Trigger Immune Effector Functions in Health and Autoimmunity
by: Doryssa Hermans, et al.
Published: (2023-03-01)

Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases
by: Jun Liu, et al.
Published: (2022-05-01)

Limited in vivo reactivity of polyclonal effector cytotoxic T cells towards altered peptide ligands.
by: Bättig, P, et al.
Published: (2005)

Yeast Display for the Identification of Peptide-MHC Ligands of Immune Receptors
by: Huisman, Brooke D, et al.
Published: (2023)

Altered peptide ligands trigger perforin- rather than Fas-dependent cell lysis.
by: Bachmann, M, et al.
Published: (1997)

Quantitative analysis of the T cell receptor signaling network in response to altered peptide ligands
by: Wille, Lucia
Published: (2006)

Protein and Peptide Array Analysis of Autoimmune Disease
by: William H. Robinson, et al.
Published: (2002-12-01)

Aberrant Expression of a Proliferation-Inducing Ligand Underlies Autoimmune Mechanisms in Immune Thrombocytopenia
by: Y. F. Hao, et al.
Published: (2021-01-01)

Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism.
by: Bachmann, M, et al.
Published: (1998)

Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes.
by: Smyth, L, et al.
Published: (1998)

Is an effective immune intervention for Alzheimer's disease in prospect?
by: Esiri, M
Published: (2001)

Immunogenic self-peptides - the great unknowns in autoimmunity: Identifying T-cell epitopes driving the autoimmune response in autoimmune diseases
by: Jörg Christoph Prinz
Published: (2023-01-01)

Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides.
by: Sewell, A, et al.
Published: (1997)

The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
by: Klenerman, P, et al.
Published: (1995)

West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligands.
by: Jung, K, et al.
Published: (2012)

Human antimicrobial peptides in autoimmunity
by: Ekaterina S. Umnyakova, et al.
Published: (2020-04-01)

On the role of the innate immunity in autoimmune disease.
by: Bachmann, M, et al.
Published: (2001)

Immune regulation and immunotherapy in autoimmune disease /
by: Zhang, Jingwu, 1956-, et al.
Published: (2007)

Immune-Neuroendocrine Interactions and Autoimmune Diseases
by: Luis J. Jara, et al.
Published: (2006-01-01)

Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets
by: Louise Magnusson, et al.
Published: (2020-02-01)

The role of cytokines in the pathogenesis of autoimmune diabetes, immune intervention issues
by: Ye. B. Kravets, et al.
Published: (2010-02-01)

Autoimmunity in Chagas' disease: immunomodulation of autoimmune and T. cruzi-specific immune responses
by: Luiz Vicente Rizzo, et al.
Published: (1988-11-01)

AUTOIMMUNE RHEUMATIC DISEASES: RESULTS AND PROSPECTS FOR RESEARCHES
by: E. L. Nasonov, et al.
Published: (2015-09-01)

Peptide Targeting of PDZ-Dependent Interactions as Pharmacological Intervention in Immune-Related Diseases
by: Luis H. Gutiérrez-González, et al.
Published: (2021-10-01)

AmiA and AliA peptide ligands, found in Klebsiella pneumoniae, are imported into pneumococci and alter the transcriptome
by: Janine Lux, et al.
Published: (2024-05-01)

Presentation of antigenic peptides by products of the major histocompatibility complex.
by: Fairchild, P
Published: (1998)

Increased polyamines alter chromatin and stabilize autoantigens in autoimmune diseases
by: Wesley H. Brooks
Published: (2013-04-01)

Increased Toll-Like Receptors Activity and TLR Ligands in Patients with Autoimmune Thyroid Diseases
by: Shiqiao Peng, et al.
Published: (2016-12-01)

Editorial: Immune and autoimmune mechanisms in cardiovascular disease
by: Holger Winkels, et al.
Published: (2023-01-01)

Peptide immunotherapy in experimental autoimmune encephalomyelitis
by: Stephen M Anderton
Published: (2015-06-01)